Given that NK cells also display PD-1 signaling [25], it seems plausible that cancer cells with their extensive expression of PD-L1 proteins can exploit the PD-1/PD-L1 pathway to suppress the anticancer armoury of the CD4+ and CD8+ T cells and NK cells, thus escaping the surveillance by the immune system. The gene discussed is PDCD1; the disease is cancer.